0001437749-18-003793.txt : 20180302
0001437749-18-003793.hdr.sgml : 20180302
20180302163128
ACCESSION NUMBER: 0001437749-18-003793
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180301
FILED AS OF DATE: 20180302
DATE AS OF CHANGE: 20180302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Klausner Mark R.
CENTRAL INDEX KEY: 0001732629
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36200
FILM NUMBER: 18662479
MAIL ADDRESS:
STREET 1: C/O OXFORD IMMUNOTEC GLOBAL
STREET 2: 94C INNOVATION DRIVE, MILTON PARK
CITY: ABINGDON, OXFORDSHIRE
STATE: X0
ZIP: OX14 4RZ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oxford Immunotec Global PLC
CENTRAL INDEX KEY: 0001586049
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
BUSINESS PHONE: 44 01235 442780
MAIL ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
4
1
rdgdoc.xml
FORM 4
X0306
4
2018-03-01
0001586049
Oxford Immunotec Global PLC
OXFD
0001732629
Klausner Mark R.
C/O OXFORD IMMUNOTEC GLOBAL
94C INNOVATION DRIVE
ABINGDON, OXFORDSHIRE
X0
OX14 4RZ
UNITED KINGDOM
1
SHARE OPTION (RIGHT TO BUY)
10.93
2018-03-01
4
A
0
3728
0
A
2028-03-01
ORDINARY SHARES
3728
3728
D
SHARE OPTION (RIGHT TO BUY)
10.93
2018-03-01
4
A
0
14914
0
A
2028-03-01
ORDINARY SHARES
14914
14914
D
This option will vest and become exercisable as to 100% of the underlying shares on the date of the first annual meeting of the issuer's shareholders held after the date of grant.
This option will vest and become exercisable as to one-third of the shares on each date on which the first three annual meetings of the issuer's shareholders are held after the date of grant.
/s/ Elizabeth M. Keiley, as Attorney-in-Fact for Mark Klausner
2018-03-02